Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 48-58
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.48
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.48
Figure 3 Kaplan-Meier survival analyses.
A: OS curves of patients in Groups A-D; B: PFS curves of patients in Groups A-D. OS: Overall survival; PFS: Progression-free survival.
- Citation: Zhu YL, Sun YK, Xue XM, Yue JY, Yang L, Xue LY. Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 2019; 11(1): 48-58
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/48.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.48